Peter J Barris's Net Worth

$2.53 Billion

Who is Peter J Barris?

Peter J Barris has an estimated net worth of $2.53 Billion. This is based on reported shares across multiple companies, which include GLU MOBILE INC, SUNESIS PHARMACEUTICALS INC, MOTRICITY INC, SOURCEFIRE INC, BOINGO WIRELESS INC, AUDIENCE INC, PEPLIN INC, ARYx Therapeutics, Inc., Data Domain, Inc., INTERCELL USA, INC., OCCAM NETWORKS INC/DE, PHARMOS CORP, SUPERNUS PHARMACEUTICALS INC, HEMOSENSE INC, Cloudflare, Inc., RHYTHM PHARMACEUTICALS, INC., OPOWER, INC., Cascadian Therapeutics, Inc., Workday, Inc., Care.com Inc, Millennial Media Inc., AEROHIVE NETWORKS, INC, Echo Global Logistics, Inc., Financial Engines, Inc., FUSION-IO, INC., MULESOFT, INC, Groupon, Inc., TriVascular Technologies, Inc., INNERWORKINGS INC, HYPERION THERAPEUTICS INC, Elastic N.V., Senseonics Holdings, Inc., Berkshire Grey, Inc., NEXTNAV INC., CHANNELADVISOR CORP, ZHONE TECHNOLOGIES INC, Bloom Energy Corp, Oyster Point Pharma, Inc., AVEO PHARMACEUTICALS INC, Zosano Pharma Corp, Sprout Social, Inc., APPIAN CORP, Mersana Therapeutics, Inc., Clovis Oncology, Inc., Mirum Pharmaceuticals, Inc., Adaptimmune Therapeutics PLC, AMICUS THERAPEUTICS INC, VONAGE HOLDINGS CORP, BOX INC, Nightstar Therapeutics plc, Tintri, Inc., Loxo Oncology, Inc., Dermira, Inc., CHAMPIONS ONCOLOGY, INC., Surface Oncology, Inc., TREVENA INC, GENOCEA BIOSCIENCES, INC., PhaseBio Pharmaceuticals Inc, Millendo Therapeutics, Inc., TARGACEPT INC, TESARO, Inc., PROTEOSTASIS THERAPEUTICS, INC., ARDELYX, INC., Galera Therapeutics, Inc., Trevi Therapeutics, Inc., GLYCOMIMETICS INC, Tracon Pharmaceuticals, Inc., SYNLOGIC, INC., Epizyme, Inc., Arsanis, Inc., Transcept Pharmaceuticals Inc, Cerecor Inc., Roka BioScience, Inc., Regulus Therapeutics Inc., ARCA biopharma, Inc., Marker Therapeutics, Inc., Omthera Pharmaceuticals, Inc., Ra Pharmaceuticals, Inc., ZeroFox Holdings, Inc., Tableau Software Inc, Neutral Tandem Inc, Strongbridge Biopharma plc, CVENT INC, Achaogen Inc, Vitae Pharmaceuticals, Inc, XOOM Corp, Liquidia Technologies Inc, ARADIGM CORP, XTERA COMMUNICATIONS, INC., INTERLEUKIN GENETICS INC, INHIBITEX, INC., INTARCIA THERAPEUTICS, INC, FOXHOLLOW TECHNOLOGIES, INC., PHARMION CORP, MYOGEN INC, ZTI MERGER SUBSIDIARY III INC, and APPLIED IMAGING CORP.

SEC CIK

Peter J Barris's CIK is 0001005561

Past Insider Trading and Trends

2007 was Peter J Barris's most active year for acquiring shares with 132 total transactions. Peter J Barris's most active month to acquire stocks was the month of February. 2014 was Peter J Barris's most active year for disposing of shares, totalling 101 transactions. Peter J Barris's most active month to dispose stocks was the month of October. 2003 saw Peter J Barris paying a total of $47,154,167.68 for 13,436,146 shares, this is the most they've acquired in one year. In 2019 Peter J Barris cashed out on 145,713,578 shares for a total of $955,271,068.92, their largest year based on trade value.